Afghanistan

in page functions
[French]
Afghanistan
Total population (2018) 34,935,680
Birth cohort (2018) 1,083,787
Surviving Infants (surviving to 1 year per year, 2018) 1,015,710
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 91/1000
World Bank Index, IDA (2015) 2.69
Gross Nation Income (per capita US$, 2015) 610
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 407

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Afghanistan

Type of support

Approvals

2001-2023 (US$)
(26 Sep 2018)

Commitments

2001-2023 (US$)
(26 Sep 2018)

Disbursements

2000-2018 (US$)
(26 Sep 2018)

% Disbursed

(26 Sep 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $317,472,224 $345,593,565 $310,595,151
Civil Society Organisation support (CSO) $3,561,578 $3,561,578 $3,877,478 109%
Health system strengthening (HSS 1) $34,100,000 $34,100,000 $34,100,000 100%
Health system strengthening (HSS 2) $17,727,209 $18,001,661 $16,469,963 93%
Health system strengthening (HSS 3) $38,117,610 $47,499,999 $20,539,953 54%
Immunisation services support (ISS) $14,025,300 $14,025,300 $14,025,300 100%
Injection Safety Devices (NVS) $1,659,500 $1,970,000 $1,974,276 119%
Injection safety support (INS) $1,676,500 $1,676,500 $1,676,500 100%
IPV (NVS) $4,099,901 $4,099,901 $3,863,001 94%
Measles SIA (NVS) $2,163,903 $2,163,903 $2,163,903 100%
Measles SIA - Operational costs (OPC) $3,574,000 $3,574,000 $3,574,000 100%
Measles-Follow-up campaign (NVS) $4,307,000 $4,307,000 $4,856,288 113%
Measles-Follow-up campaign op.costs (OPC) $8,702,377 $8,702,377 $8,702,377 100%
Penta (NVS) $70,372,886 $72,191,386 $70,391,416 100%
Pneumo (NVS) $94,191,604 $105,474,604 $104,651,726 111%
Product Switch Grant (PSG) $405,821 $405,821 $405,821 100%
Rotavirus (NVS) $5,393,500 $10,446,000 $5,929,614 110%
Tetra DTP-HepB (NVS) $9,903,633 $9,903,633 $9,903,633 100%
Vaccine Introduction Grant (VIG) $3,489,902 $3,489,902 $3,489,902 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Afghanistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 81%
M:F sex ratio at birth (2018) 1.06
Household survey: DTP3 coverage for male (2010) 41.60%
Household survey: DTP3 coverage for female (2010) 38.90%
Household survey: Last DTP3 survey (2010) 40%
% districts achieving > 80% DTP3 coverage (2017) 68%
% districts achieving < 50% DTP3 coverage (2017) 6%
MCV WHO/UNICEF estimates (2017) 62%

Breakdown of support

Non-vaccine support Vaccine support
34% 66%
$106,861,294 $203,733,857

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Afghanistan

01 September 2018

Afghanistan measles campaign

Measles vaccine campaign launched in Afghanistan

Nearly 14 million children in Afghanistan to be immunised against measles following a growing increase in reported cases.

31 July 2018

INFUSE workshop

Fingerprint records and digital health cards to help solve global identity crisis

Four companies will receive Gavi support to help scale emerging digital identification technologies in developing countries.

11 July 2018

Every Child Counts The Gambia programme

Shifo & Gavi join hands to help make vaccines work for every child

The Shifo Foundation, in collaboration with Gavi and other key partners will work to strengthen registration and data quality across The Gambia and ensure no child misses out on life-saving vaccines.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here